Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $762.17 ($76K) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Scheduled sale ($76k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $752.11 | 2 | $2K | 2.0% |
| 2 | $753.54 | 18 | $14K | 17.9% |
| 3 | $754.45 | 17 | $13K | 17.0% |
| 4 | $755.50 | 17 | $13K | 17.0% |
| 5 | $756.77 | 24 | $18K | 24.0% |
| 6 | $757.29 | 2 |
| $2K |
| 2.0% |
| 7 | $758.58 | 7 | $5K | 7.0% |
| 8 | $759.65 | 4 | $3K | 4.0% |
| 9 | $760.40 | 4 | $3K | 4.0% |
| 10 | $761.58 | 3 | $2K | 3.0% |
| 11 | $762.17 | 2 | $2K | 2.0% |
| Total | $756.13 avg | 100 | $76K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |